• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

Enstilar

LEO Pharma announces regulatory submission of Enstilar for psoriasis in Europe

Posted on: 27 March 2015 | Source: Victoria White

LEO Pharma has announced it submitted a MAA to 30 European Health Authorities for Enstilar cutaneous foam for the treatment of psoriasis vulgaris...

antibiotics

Antibiotics pipeline boasts 741 products, but first-in-class development remains low, says GBI Research

Posted on: 27 March 2015 | Source: Victoria White

While antibiotics boast a vast pipeline, the majority is dominated by generics, as weak financial incentives and high fail rates have discouraged innovation..

nova nordisk saxenda

Novo Nordisk has decided to resubmit the New Drug Applications of Tresiba® and Ryzodeg® in the US

Posted on: 27 March 2015 | Source: Victoria White

Novo Nordisk has announced that it has decided to resubmit New Drug Applications of Tresiba and Ryzodeg to the FDA within the month.

quadracel

Sanofi Pasteur announces FDA approval of Quadracel DTaP-IPV vaccine for children aged 4 to 6

Posted on: 26 March 2015 | Source: Victoria White

Sanofi Pasteur announces the FDA approval of Quadracel for immunisation against diphtheria, tetanus, pertussis and poliomyelitis in children aged 4 to 6...

pharmaceutical market

Germany’s pharmaceutical market value will crawl to $65 billion by 2020, says GlobalData

Posted on: 26 March 2015 | Source: Victoria White

Germany pharmaceutical market value, valued at $58.6 billion in 2014, will grow modestly to reach an estimated $65 billion by 2020, says GlobalData...

cell therapy

Apceth initiates Phase II clinical trial for pioneering engineered cell therapy to treat gastrointestinal cancer

Posted on: 26 March 2015 | Source: Victoria White

Apceth has announced the successful completion of the Phase I and initiation of the Phase II with the engineered cell therapy product Agenmestencel-T...

sepsis

Sepsis-specific treatment market will expand from 2016 and reach $354 million by 2021

Posted on: 26 March 2015 | Source: Victoria White

Following the first sepsis-specific product launch in 2016, the treatment market will expand to reach $354 million by 2021, says GlobalData...

anthrax

Emergent BioSolutions receives FDA approval of Anthrasil for use in the treatment of inhalational anthrax

Posted on: 26 March 2015 | Source: Victoria White

Emergent BioSolutions has announced that the FDA has approved Anthrasil for treatment of inhalational anthrax in combination with antibacterial drugs...

onychomycosis nail

Moberg Pharma announces grant of EU Patent for MOB-015 related to topical treatment of onychomycosis

Posted on: 26 March 2015 | Source: Victoria White

Moberg Pharma today announced that the European Patent Office has issued a Patent relating to its topical treatment MOB-015 for onychomycosis (nail fungus)...

who transparency

WHO report shows that transparency and cooperation help to reduce high prices for new medicines

Posted on: 26 March 2015 | Source: Victoria White

Governments are finding it increasingly difficult to afford new medicines. A WHO report suggests transparency is needed for the negotiation of better deals...

Tanezumab

Pfizer and Lilly preparing to resume Phase 3 chronic pain programme for Tanezumab

Posted on: 25 March 2015 | Source: Victoria White

Pfizer Inc. and Eli Lilly and Company have announced that they are preparing to resume the Phase 3 clinical programme for tanezumab...

nexafed

Acura Pharmaceuticals reports successful topline results from Nexafed extended-release clinical study

Posted on: 25 March 2015 | Source: Victoria White

Acura has announced preliminary results from a clinical study which demonstrated bioequivalence of one formulation of NEXAFED tablets to Sudafed tablets...